Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26199220 | 0.94 | USP2 (0.32) | SMN1; SMN2HPGDHTT | |
| SCHEMBL26199214 | 0.90 | SMN1; SMN2 (0.34) | MEN1KMT2ASMN1; SMN2HPGDHTT | |
| SCHEMBL26199212 | 0.84 | USP2 (0.32) | SMN1; SMN2HPGDHTT | |
| SCHEMBL12981918 | 0.84 | HPGD (0.36) | MEN1KMT2ASMN1; SMN2HPGDHTT | |
| SCHEMBL16471749 | 0.83 | SMN1; SMN2 (0.37) | MEN1KMT2ASMN1; SMN2HPGDHTT | |
| SCHEMBL8635388 | 0.82 | PSMB8 (0.32) | KMT2ASMN1; SMN2HPGDHTT | |
| SCHEMBL24621700 | 0.82 | ADORA3 (0.33) | — | |
| SCHEMBL17167184 | 0.82 | ADORA3 (0.33) | — | |
| SCHEMBL13226861 | 0.81 | HPGD (0.36) | MEN1KMT2ASMN1; SMN2HPGDHTT | |
| SCHEMBL12981636 | 0.81 | HPGD (0.46) | MEN1KMT2ASMN1; SMN2HPGDHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230279476-A1 | NOVEL ACRYLATE DERIVATIVES AND USES THEREOF | EXPANSION TECHNOLOGIES (US) | 2023-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230279476-A1 | NOVEL ACRYLATE DERIVATIVES AND USES THEREOF | DCLRE1A, ACR, PHAX | MEN1 4026/4885KMT2A 3464/4885SMN1; SMN2 2572/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.